Corcept Therapeutics IncorporatedCorcept Therapeutics IncorporatedCorcept Therapeutics Incorporated

Corcept Therapeutics Incorporated

No trades
See on Supercharts

Price target

74.900.000.00%
The 5 analysts offering 1 year price forecasts for CORT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to CORT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CORT EPS for the last quarter is 0.41 USD despite the estimation of 0.28 USD. In the next quarter EPS is expected to reach 0.38 USD. Track more of Corcept Therapeutics Incorporated financials and stay on top of what is up with the company.
In the next quarter Corcept Therapeutics Incorporated revenue is expected to reach ‪198.04 M‬ USD. Check out Corcept Therapeutics Incorporated revenue and earnings and make informed decisions.
According to analysts, CORT price target is 74.90 USD with a max estimate of 80.00 USD and a min estimate of 67.00 USD. Check if this forecast comes true in a year, meanwhile watch Corcept Therapeutics Incorporated stock price chart and keep track of the current situation with CORT news and stock market news.
We've gathered opinions of 5 analysts rating CORT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.